Send us a text Why are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine? In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI. Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets....
All content for Digital Pathology Podcast is the property of Aleksandra Zuraw, DVM, PhD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text Why are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine? In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI. Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets....
167: Why Accuracy Matters in Digital Pathology Podcast with Keith Wharton, Jr.
Digital Pathology Podcast
1 hour 36 minutes
1 month ago
167: Why Accuracy Matters in Digital Pathology Podcast with Keith Wharton, Jr.
Send us a text Why do some pathologists still hesitate to trust digital slides—even after the FDA says “yes”? Because accuracy in digital pathology isn’t just about pixels—it’s about precision, validation, and confidence. In this episode, I talk with Dr. Keith Wharton, MD, PhD, Global Medical Director at Roche Diagnostics, about how the Roche Digital Pathology DX system earned its FDA clearance for primary diagnosis—and what that means for the field. We explore the science and strategy behind...
Digital Pathology Podcast
Send us a text Why are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine? In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI. Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets....
